Fecal microbiota transplantation alleviates mild‐moderate COVID‐19 associated diarrhoea and depression symptoms: A prospective study of a randomized, double‐blind clinical trial

Documenti analoghi

• Incidence and risk factors of de novo hepatitis E virus infection after receiving liver transplantation
  di: Ping He, et al.
  Pubblicazione: (2024)
• Multikingdom characterization of gut microbiota in patients with rheumatoid arthritis and rheumatoid arthritis‐associated interstitial lung disease
  di: Yida Xing, et al.
  Pubblicazione: (2024)
• Spleen tyrosine kinase inhibitor R406 has both antiviral and anti‐inflammatory effects on severe influenza A infection
  di: Junhao Luo, et al.
  Pubblicazione: (2024)
• Prevalence and risk factors of long COVID among maintenance hemodialysis patients post SARS‐CoV‐2 infection: A one‐year follow‐up study in China
  di: Xue Zhao, et al.
  Pubblicazione: (2024)
• A prospective humoral immune monitoring study of kidney transplant recipients receiving three doses of SARS‐CoV‐2 mRNA vaccine
  di: Cinzia Borgogna, et al.
  Pubblicazione: (2024)